GO:0036094 | small molecule binding | 16.91% (23/136) | 2.03 | 0.0 | 2e-06 |
GO:0000166 | nucleotide binding | 15.44% (21/136) | 1.96 | 0.0 | 4e-06 |
GO:1901265 | nucleoside phosphate binding | 15.44% (21/136) | 1.96 | 0.0 | 4e-06 |
GO:0008144 | drug binding | 13.97% (19/136) | 2.14 | 0.0 | 5e-06 |
GO:0005488 | binding | 30.88% (42/136) | 1.24 | 0.0 | 5e-06 |
GO:0030554 | adenyl nucleotide binding | 13.24% (18/136) | 2.11 | 0.0 | 5e-06 |
GO:0032559 | adenyl ribonucleotide binding | 13.24% (18/136) | 2.12 | 0.0 | 6e-06 |
GO:0005524 | ATP binding | 13.24% (18/136) | 2.13 | 0.0 | 6e-06 |
GO:0043168 | anion binding | 14.71% (20/136) | 1.89 | 0.0 | 1.1e-05 |
GO:0097367 | carbohydrate derivative binding | 13.97% (19/136) | 1.93 | 1e-06 | 1.3e-05 |
GO:0035639 | purine ribonucleoside triphosphate binding | 13.24% (18/136) | 1.9 | 2e-06 | 3.3e-05 |
GO:0017076 | purine nucleotide binding | 13.24% (18/136) | 1.88 | 2e-06 | 3.3e-05 |
GO:0032555 | purine ribonucleotide binding | 13.24% (18/136) | 1.89 | 2e-06 | 3.3e-05 |
GO:0032553 | ribonucleotide binding | 13.24% (18/136) | 1.86 | 2e-06 | 3.9e-05 |
GO:0043167 | ion binding | 16.18% (22/136) | 1.55 | 5e-06 | 7.9e-05 |
GO:0006259 | DNA metabolic process | 6.62% (9/136) | 2.84 | 5e-06 | 8.1e-05 |
GO:1901363 | heterocyclic compound binding | 17.65% (24/136) | 1.45 | 7e-06 | 8.5e-05 |
GO:0097159 | organic cyclic compound binding | 17.65% (24/136) | 1.45 | 7e-06 | 8.5e-05 |
GO:0030983 | mismatched DNA binding | 2.21% (3/136) | 5.63 | 2.6e-05 | 0.00032 |
GO:0006298 | mismatch repair | 2.21% (3/136) | 5.5 | 3.5e-05 | 0.000403 |
GO:0003674 | molecular_function | 35.29% (48/136) | 0.74 | 9.3e-05 | 0.00103 |
GO:0006281 | DNA repair | 3.68% (5/136) | 3.29 | 0.000166 | 0.001754 |
GO:0051716 | cellular response to stimulus | 3.68% (5/136) | 3.23 | 0.000202 | 0.001881 |
GO:0006974 | cellular response to DNA damage stimulus | 3.68% (5/136) | 3.23 | 0.000202 | 0.001881 |
GO:0033554 | cellular response to stress | 3.68% (5/136) | 3.23 | 0.000202 | 0.001881 |
GO:0006950 | response to stress | 3.68% (5/136) | 3.1 | 0.000305 | 0.002538 |
GO:0051129 | negative regulation of cellular component organization | 1.47% (2/136) | 6.18 | 0.000298 | 0.002569 |
GO:0010639 | negative regulation of organelle organization | 1.47% (2/136) | 6.18 | 0.000298 | 0.002569 |
GO:0050896 | response to stimulus | 3.68% (5/136) | 2.92 | 0.000539 | 0.004334 |
GO:0005634 | nucleus | 2.94% (4/136) | 3.4 | 0.000576 | 0.004473 |
GO:0003690 | double-stranded DNA binding | 2.21% (3/136) | 4.0 | 0.000862 | 0.006479 |
GO:0090304 | nucleic acid metabolic process | 6.62% (9/136) | 1.83 | 0.001053 | 0.00767 |
GO:0006260 | DNA replication | 2.21% (3/136) | 3.77 | 0.001389 | 0.00981 |
GO:0043231 | intracellular membrane-bounded organelle | 2.94% (4/136) | 2.98 | 0.001689 | 0.01093 |
GO:0043227 | membrane-bounded organelle | 2.94% (4/136) | 2.98 | 0.001689 | 0.01093 |
GO:0033043 | regulation of organelle organization | 1.47% (2/136) | 5.05 | 0.001602 | 0.010978 |
GO:0051095 | regulation of helicase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0051097 | negative regulation of helicase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0010826 | negative regulation of centrosome duplication | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:1905463 | negative regulation of DNA duplex unwinding | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:1905462 | regulation of DNA duplex unwinding | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:1905775 | negative regulation of DNA helicase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:1905774 | regulation of DNA helicase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0010824 | regulation of centrosome duplication | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0019206 | nucleoside kinase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0019692 | deoxyribose phosphate metabolic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0050797 | thymidylate synthase (FAD) activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0046605 | regulation of centrosome cycle | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0046606 | negative regulation of centrosome cycle | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0046385 | deoxyribose phosphate biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0046073 | dTMP metabolic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0019136 | deoxynucleoside kinase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0004797 | thymidine kinase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0042555 | MCM complex | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0032886 | regulation of microtubule-based process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0006231 | dTMP biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0036038 | MKS complex | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.74% (1/136) | 7.5 | 0.005506 | 0.015837 |
GO:0005515 | protein binding | 11.76% (16/136) | 1.14 | 0.002523 | 0.015889 |
GO:0051128 | regulation of cellular component organization | 1.47% (2/136) | 4.7 | 0.002622 | 0.016077 |
GO:0046483 | heterocycle metabolic process | 7.35% (10/136) | 1.36 | 0.005832 | 0.016572 |
GO:0006725 | cellular aromatic compound metabolic process | 7.35% (10/136) | 1.36 | 0.006003 | 0.016851 |
GO:0048523 | negative regulation of cellular process | 1.47% (2/136) | 4.6 | 0.003014 | 0.01801 |
GO:1901360 | organic cyclic compound metabolic process | 7.35% (10/136) | 1.33 | 0.006599 | 0.018305 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.35% (10/136) | 1.46 | 0.003701 | 0.021557 |
GO:0003677 | DNA binding | 4.41% (6/136) | 2.02 | 0.003814 | 0.021676 |
GO:0140097 | catalytic activity, acting on DNA | 2.21% (3/136) | 3.21 | 0.004237 | 0.023506 |
GO:0048519 | negative regulation of biological process | 1.47% (2/136) | 4.26 | 0.004839 | 0.026221 |
GO:0019787 | ubiquitin-like protein transferase activity | 1.47% (2/136) | 3.65 | 0.011084 | 0.026353 |
GO:0004842 | ubiquitin-protein transferase activity | 1.47% (2/136) | 3.65 | 0.011084 | 0.026353 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.47% (2/136) | 3.75 | 0.009652 | 0.026457 |
GO:0003676 | nucleic acid binding | 6.62% (9/136) | 1.31 | 0.011058 | 0.026839 |
GO:0120036 | plasma membrane bounded cell projection organization | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0030030 | cell projection organization | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0010948 | negative regulation of cell cycle process | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0044782 | cilium organization | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0030031 | cell projection assembly | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0060271 | cilium assembly | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0120031 | plasma membrane bounded cell projection assembly | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:2001251 | negative regulation of chromosome organization | 0.74% (1/136) | 6.5 | 0.010981 | 0.026933 |
GO:0044260 | cellular macromolecule metabolic process | 8.09% (11/136) | 1.31 | 0.005106 | 0.02704 |
GO:0034061 | DNA polymerase activity | 1.47% (2/136) | 3.7 | 0.010357 | 0.02806 |
GO:0034641 | cellular nitrogen compound metabolic process | 7.35% (10/136) | 1.18 | 0.013509 | 0.031795 |
GO:0019205 | nucleobase-containing compound kinase activity | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0044092 | negative regulation of molecular function | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0006220 | pyrimidine nucleotide metabolic process | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0043086 | negative regulation of catalytic activity | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0051346 | negative regulation of hydrolase activity | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0051494 | negative regulation of cytoskeleton organization | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0008658 | penicillin binding | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0033293 | monocarboxylic acid binding | 0.74% (1/136) | 5.92 | 0.016427 | 0.035439 |
GO:0044463 | cell projection part | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0043015 | gamma-tubulin binding | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0033044 | regulation of chromosome organization | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0044441 | ciliary part | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0120038 | plasma membrane bounded cell projection part | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0043177 | organic acid binding | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0051336 | regulation of hydrolase activity | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0031406 | carboxylic acid binding | 0.74% (1/136) | 5.5 | 0.021843 | 0.043499 |
GO:0043229 | intracellular organelle | 2.94% (4/136) | 1.91 | 0.02218 | 0.043796 |
GO:0043226 | organelle | 2.94% (4/136) | 1.9 | 0.02293 | 0.044896 |